SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: kfdkfd who wrote (11883)2/23/1998 5:14:00 PM
From: Jack Zahran  Read Replies (2) | Respond to of 31646
 
I can't wait to read about both the Unilever and BMY pilots becoming full blown contracts. If the Unilever proposal is a 7.5 Million dollar contract after the pilot, it's easy to understand that it will take a few weeks for the company to work out the approvals (Same with BMY).

JZ



To: kfdkfd who wrote (11883)2/24/1998 9:17:00 AM
From: Steve Sanchez  Respond to of 31646
 
from the vcall Tava CC transcript:

Willard Brown: Well correlary to this question is that the Y2K
activity for your company, it doesn't necessarily end, I would imagine,
in the year 2000 because a lot of these projects won't be finished.
Could youcomment on that?

John Jenkins: ... for us, for this organization, the audience
that we're getting now, multi-plan engagements, provides a tremendous
opportunity for us to restructure our base business. We've done
business with Bristol-Myers Squibb in the past on a plant-by-plant
basis. But now we're engaged across 125 plants, single point
of contact, and certainly would expect to - I mean, we do our job right
- expect to stay engaged at that level and provide our core services to
that audience after year 2000. So it's a major opportunity, as we've
said, for us from both ends.